Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

The Lancet

Volumn 386, Issue 9996, 2015, Pages 857-866

  Henao Restrepo, Ana Maria ^a   Longini, Ira M ^b   Egger, Matthias ^c,d   Dean, Natalie E ^b   Edmunds, W John ^e   Camacho, Anton ^e   Carroll, Miles W ^f,g   Doumbia, Moussa ^h   Draguez, Bertrand ⁱ   Duraffour, Sophie ^g   Enwere, Godwin ^a   Grais, Rebecca ^j   Gunther, Stephan ^g   Hossmann, Stefanie ^c   Kondé, Mandy Kader ^k   Kone, Souleymane ^a   Kuisma, Eeva ^f,g   Levine, Myron M ^l   Mandal, Sema ^f   Norheim, Gunnstein ^m   Riveros, Ximena ^a   Soumah, Aboubacar ^j   Trelle, Sven ^c   Vicari, Andrea S ^a   Watson, Conall H ^e   Kéïta, Sakoba ^o   Kieny, Marie Paule ^a   Røttingen, John Arne ^m,n,p   more..

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

^g BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^h Centre pour le Developpement des Vaccins   (Mali)

ⁱ MÉDECINS SANS FRONTIÈRES   (Belgium)

^j EPICENTRE   (France)

^k CEFORPAG   (Guinea)

^l UNIVERSITY OF MARYLAND   (United States)

^m NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

ⁿ UNIVERSITY OF OSLO   (Norway)

^o Ministry of Health   (Guinea)

^p HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA VACCINE; UNCLASSIFIED DRUG; VESICULAR STOMATITIS VIRUS VECTOR; VIRUS GLYCOPROTEIN; VIRUS VECTOR; MEMBRANE PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DELTOID MUSCLE; DRUG EFFICACY; DRUG SAFETY; EBOLA HEMORRHAGIC FEVER; FEMALE; FEVER; GUINEA; HUMAN; INCUBATION TIME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TRAFFIC ACCIDENT; VESICULOVIRUS; ZAIRE EBOLAVIRUS; EBOLAVIRUS; GENE VECTOR; HEMORRHAGIC FEVER, EBOLA; IMMUNOLOGY; INCIDENCE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PROCEDURES; VACCINATION; YOUNG ADULT;

ADULT; EBOLA VACCINES; EBOLAVIRUS; FEMALE; GENETIC VECTORS; GUINEA; HEMORRHAGIC FEVER, EBOLA; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; VACCINATION; VESICULOVIRUS; YOUNG ADULT;

EID: 84940952795     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)61117-5     Document Type: Article

References (25)

1. R Kanapathipillai, AM Henao Restrepo, P Fast et al. Ebola vaccine - an urgent international priority N Engl J Med 371 2014 2249 2251
2. NJ Sullivan, L Hensley, C Asiedu et al. CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates Nat Med 17 2011 1128 1131
3. TW Geisbert, H Feldmann Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections J Infect Dis 204 suppl 2011 S1075 S1081
4. TW Geisbert, JB Geisbert, A Leung et al. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus J Virol 83 2009 7296 7304
5. F-C Zhu, L-H Hou, J-X Li et al. Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial Lancet 385 2015 2272 2279
6. JA Regules, JH Beigel, KM Paolino for the rVSVΔG-ZEBOV-GP Study Group A recombinant vesicular stomatitis virus Ebola vaccine - preliminary report N Engl J Med 2015 10.1056/NEJMoa1414216 published online April 1.
7. ST Agnandji, A Huttner, ME Zinser et al. Phase 1 trials of rVSV Ebola vaccine in Africa and Europe - preliminary report N Engl J Med 2015 10.1056/NEJMoa1502924 published online April 1.
8. JE Ledgerwood, AD DeZure, DA Stanley the VRC 207 Study Team Chimpanzee adenovirus vector Ebola vaccine - preliminary report N Engl J Med 2014 10.1056/NEJMoa1410863 published online Nov 26.
9. T Rampling, K Ewer, G Bowyer et al. A monovalent chimpanzee adenovirus Ebola vaccine - preliminary report N Engl J Med 2015 10.1056/NEJMoa1411627 published online Jan 28.
10. Ebola ça Suffit Ring Vaccination Trial Consortium The ring vaccination trial: a novel cluster randomized controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola BMJ 351 2015 h3740
11. F Fenner, D Henderson, I Arita, I Ladnyi Smallpox and its eradication http://whqlibdoc.who.int/smallpox/9241561106.pdf (accessed July 22, 2015).
12. WHO Contact tracing during an outbreak of Ebola virus disease http://www.who.int/csr/resources/publications/ebola/contact-tracing/en/ (accessed Dec 22, 2014).
13. WHO Laboratory guidance for the diagnosis of Ebola virus disease. Interim recommendations http://apps.who.int/iris/bitstream/10665/134009/1/WHO-EVD-GUIDANCE-LAB-14.1-eng.pdf?ua=1 (accessed Dec 22, 2014).
14. WHO Case definition recommendations for Ebola or Marburg virus disease http://www.who.int/csr/resources/publications/ebola/ebola-case-definition-contact-en.pdf 2014 (accessed July 22, 2015).
15. RJ Hayes, LH Moulton Cluster randomised trials 2008 Chapman & Hall/CRC London
16. A Donner, N Klar Design and analysis of cluster randomization trials in health research 2000 Arnold London
17. PC O'Brien, T Fleming A multiple testing procedure for clinical trials Biometrics 35 1979 549 556
18. ME Halloran, IM Longini Jr, CJ Struchiner Design and analysis of vaccine studies http://www.springer.com/public+health/book/978-0-387-40313-7 (accessed Jan 22, 2015).
19. O Aalen, O Borgan, H Gjessing Survival and event history analysis - a process point of view http://www.springer.com/mathematics/probability/book/978-0-387-20287-7 (accessed Dec 2, 2014).
20. R Core Team R: a language and environment for statistical computing 2008 R Foundation for Statistical Computing Vienna, Austria
21. S Puffer, D Torgerson, J Watson Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals BMJ 327 2003 785 789
22. KF Schulz Subverting randomization in controlled trials JAMA 274 1995 1456 1458
23. WHO Ebola Response Team Ebola virus disease in west Africa - the first 9 months of the epidemic and forward projections N Engl J Med 371 2014 1481 1495
24. J Agua-Agum, A Ariyarajah, IM Blake et al. Ebola virus disease among children in West Africa N Engl J Med 372 2015 1274 1277
25. WHO Situation reports on Ebola response roadmap http://www.who.int/csr/disease/ebola/situation-reports/archive/en/ (accessed July 20, 2015).